Cushing's Hub

A resource for healthcare professionals caring for patients with Cushing’s syndrome

This editorial recaps on the achievements of Cushing’s Hub to date and highlights the latest additions to the content which include an exploration of the common complications of Cushing’s syndrome (see Varlamov EV, et al. Animated Abstract); the exciting advances in our understanding of the genetic basis of GIP-dependent PBMAH (see Chasseloup, et al. Publication Highlight); and the forthcoming Interactive Clinical Case by Dr Niki Karavitaki on the challenges of identifying Cushing’s patients.
Latest from across Cushing's Hub
News
|
June 23, 2022

Findings from two studies highlight that mortality rates are elevated among patients with Cushing’s syndrome compared with healthy individuals, and this increased risk is attenuated, but still significant, in those who have achieved remission.

Publication Highlight
|
June 23, 2022

The European Reference Network on Rare Endocrine Conditions surveyed the prevention of venous thromboembolism in Cushing’s syndrome patients in European reference centers. Read the Publication Highlight to see the results reported by van Haalen et al. on behalf of the Endo-ERN Cushing and Thrombosis Study Group.

News
|
May 5, 2022

Treatment with the 11β-hydroxylase inhibitor osilodrostat normalizes cortisol levels in the majority of patients with Cushing’s disease, report Mônica Gadelha and co-investigators from the LINC 4 trial.

From the Editorial Board: Welcome to Cushing’s Hub

“A website on Cushing’s syndrome? Why would I be interested in a website like that?”
The Editorial Board Members describe the importance of a website dedicated to Cushing’s syndrome and the reasons they signed up for the project.